Antibiotic resistance plasmids and mobile genetic elements of Clostridium perfringens Original paper

What was reviewed?

This review examined the role of antibiotic resistance plasmids and mobile genetic elements in Clostridium perfringens, focusing on how conjugative plasmids, integrative mobilizable elements, and insertion sequences drive the spread of antibiotic resistance and virulence determinants within the gut microbiome. The authors synthesized molecular, genetic, and epidemiological evidence to explain how the pCW3-like plasmid family serves as the central backbone for resistance gene dissemination, including tetracycline, chloramphenicol, bacitracin, and lincomycin resistance determinants. The review emphasized that these plasmids not only encode resistance genes directly but also facilitate the transfer of secondary mobile elements, thereby amplifying resistance dissemination.

Who was reviewed?

The review evaluated plasmids, resistance determinants, and mobile genetic elements identified across multiple Clostridium perfringens strains isolated from humans, livestock, poultry, and environmental microbiomes, along with related resistance elements found in other gut-associated bacteria such as Clostridioides difficile, Streptococcus agalactiae, and Coprococcus species. These organisms represent members of the intestinal microbiome that either harbor or exchange resistance determinants with C. perfringens, demonstrating that resistance genes circulate within polymicrobial gut ecosystems rather than remaining confined to a single species. The review integrated genomic, molecular, and functional studies from both clinical and agricultural settings, showing that plasmids such as pCW3 and its derivatives are widely distributed geographically and across host species, reflecting a broad microbiome reservoir of transferable resistance genes.

What were the most important findings?

The most important finding was that pCW3-like conjugative plasmids represent the dominant microbial platform for antibiotic resistance dissemination in Clostridium perfringens, functioning as highly efficient gene transfer vehicles within the intestinal microbiome. These plasmids encode the Tet(P) tetracycline resistance operon, which includes both efflux and ribosomal protection mechanisms, and are nearly universally present in tetracycline-resistant strains, making tetracycline resistance a major microbial association (MMA) signature of plasmid-bearing C. perfringens. These plasmids also facilitate mobilization of integrative elements such as Tn4451, which carries the catP gene conferring chloramphenicol resistance, ICECp1, which encodes bacitracin resistance via the bcrRABD efflux system, and tISCpe8, which encodes lincomycin resistance via lnuP. Importantly, these mobile elements can excise, circularize, and reintegrate into new genomic or plasmid locations, enabling lateral gene transfer within the microbiome. The review further showed that these plasmids encode tcp conjugation loci, a type IV secretion system that enables high-frequency plasmid transfer between bacterial cells, including strains co-existing in the same gut environment. These plasmids also carry toxin genes, meaning resistance and virulence traits co-transfer together, amplifying pathogenic potential. The presence of similar mobile resistance elements across diverse gut bacterial genera confirmed that the intestinal microbiome serves as a shared resistance gene reservoir, allowing rapid adaptation and persistence of pathogenic C. perfringens strains.

What are the greatest implications of this study?

This review establishes that antibiotic resistance and virulence in Clostridium perfringens are fundamentally microbiome-driven processes mediated by highly mobile plasmids that enable rapid adaptation and pathogenic expansion. The identification of pCW3-like plasmids as central resistance and virulence hubs means that clinicians should interpret detection of plasmid-associated resistance genes, particularly tetA(P), catP, bcrRABD, and lnuP, as markers of enhanced pathogenic potential and treatment resistance. These findings also show that antibiotic exposure, especially in agriculture, promotes expansion and horizontal transfer of resistance genes across gut microbiota, increasing the risk of treatment-resistant infections. From a microbiome signatures perspective, the expansion of plasmid-positive C. perfringens strains represents a key dysbiosis marker that signals elevated toxin production potential, resistance persistence, and increased disease risk. Therapeutically, interventions targeting plasmid transfer mechanisms, conjugation systems, or microbiome ecological balance may reduce resistance dissemination and pathogenic colonization, representing a critical frontier for infection prevention and microbiome-based therapeutic strategies.